These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9685515)
1. Endothelin-1 and Paget's bone disease: is there a link? Tarquini R; Perfetto F; Tarquini B Calcif Tissue Int; 1998 Aug; 63(2):118-20. PubMed ID: 9685515 [TBL] [Abstract][Full Text] [Related]
2. Biochemical measurements in Paget's disease of bone. Russell RG; Colwell A; Hannon RA; Blumsohn A; al-Dehaimi AW; Assiri AM; Peel NF; Eastell R Semin Arthritis Rheum; 1994 Feb; 23(4):240-1. PubMed ID: 8009238 [No Abstract] [Full Text] [Related]
3. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone. Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096 [TBL] [Abstract][Full Text] [Related]
4. Endothelin-1 levels in patients with Paget's disease of bone. Pirzer R; Tilly N; Sommer U; Liegibel U; Grafe I; Nawroth P; Kasperk C Exp Clin Endocrinol Diabetes; 2005 Dec; 113(10):598-601. PubMed ID: 16320159 [TBL] [Abstract][Full Text] [Related]
5. Relationship between biochemical markers of bone turnover and bone scintigraphic indices in assessment of Paget's disease activity. Alvarez L; Peris P; Pons F; Guañabens N; Herranz R; Monegal A; Bedini JL; Deulofeu R; Martínez de Osaba MJ; Muñoz-Gómez J; Ballesta AM Arthritis Rheum; 1997 Mar; 40(3):461-8. PubMed ID: 9082934 [TBL] [Abstract][Full Text] [Related]
6. Galactosyl hydroxylysine in assessment of Paget's bone disease. Michalsky M; Stepan JJ; Wilczek H; Formankova J; Moro L Clin Chim Acta; 1995 Jan; 234(1-2):101-8. PubMed ID: 7758208 [TBL] [Abstract][Full Text] [Related]
7. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone. Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654 [TBL] [Abstract][Full Text] [Related]
8. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling. Torres R; de la Piedra C; Rapado A Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290 [TBL] [Abstract][Full Text] [Related]
9. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease. Alvarez L; Guañabens N; Peris P; Monegal A; Bedini JL; Deulofeu R; Martinez de Osaba MJ; Muñoz-Gomez J; Rivera-Fillat F; Ballesta AM J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468 [TBL] [Abstract][Full Text] [Related]
10. Low serum magnesium concentration in Paget's disease of bone (osteitis deformans). Taylor WH Ann Clin Biochem; 1985 Nov; 22 ( Pt 6)():591-5. PubMed ID: 4073791 [TBL] [Abstract][Full Text] [Related]
11. Bone turnover markers in Paget's disease of the bone: A Systematic review and meta-analysis. Al Nofal AA; Altayar O; BenKhadra K; Qasim Agha OQ; Asi N; Nabhan M; Prokop LJ; Tebben P; Murad MH Osteoporos Int; 2015 Jul; 26(7):1875-91. PubMed ID: 26037791 [TBL] [Abstract][Full Text] [Related]
12. Serum cathepsin K concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Meier C; Meinhardt U; Greenfield JR; De Winter J; Nguyen TV; Dunstan CR; Seibel MJ Clin Lab; 2006; 52(1-2):1-10. PubMed ID: 16506358 [TBL] [Abstract][Full Text] [Related]
13. [Use of biochemical markers of bone turnover in Paget's disease of bone]. Vignot E; Meunier PJ Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680 [No Abstract] [Full Text] [Related]
14. An evaluation of serum osteocalcin in Paget's disease of bone and its response to diphosphonate treatment. Coulton LA; Preston CJ; Couch M; Kanis JA Arthritis Rheum; 1988 Sep; 31(9):1142-7. PubMed ID: 3048274 [TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous pamidronate therapy on Paget's disease of bone. Bombassei GJ; Yocono M; Raisz LG Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981 [TBL] [Abstract][Full Text] [Related]
16. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates. Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438 [TBL] [Abstract][Full Text] [Related]
17. Tartrate-resistant acid phosphatase 5b, but not periostin, is useful for assessing Paget's disease of bone. Guañabens N; Filella X; Florez H; Ruiz-Gaspá S; Conesa A; Peris P; Monegal A; Torres F Bone; 2019 Jul; 124():132-136. PubMed ID: 31051316 [TBL] [Abstract][Full Text] [Related]
18. Use of gallium to treat Paget's disease of bone: a pilot study. Matkovic V; Apseloff G; Shepard DR; Gerber N Lancet; 1990 Jan; 335(8681):72-5. PubMed ID: 1967419 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of circulating type I procollagen propeptides in patients with Paget's disease of bone. Bonnin MR; Moragues C; Nolla JM; Lirón FJ; Roig-Escofet D; Navarro MA Clin Chem Lab Med; 1998 Jan; 36(1):53-5. PubMed ID: 9594087 [TBL] [Abstract][Full Text] [Related]
20. Variable efficacy of bone remodeling biochemical markers in the management of patients with Paget's disease of bone treated with tiludronate. de la Piedra C; Rapado A; Díaz Diego EM; Díaz Martín MA; Aguirre C; López Gavilanes E; Díaz Curiel M Calcif Tissue Int; 1996 Aug; 59(2):95-9. PubMed ID: 8687976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]